PI
Putnam Investments Portfolio holdings
AUM
$75.7B
1-Year Return
34.47%
This Quarter Return
+13.42%
1 Year Return
+34.47%
3 Year Return
+62.08%
5 Year Return
+203.67%
10 Year Return
+403.53%
AUM
$75.7B
AUM Growth
+$9.96B
(+15%)
Cap. Flow
+$1.95B
Cap. Flow
% of AUM
2.58%
Top 10 Holdings %
Top 10 Hldgs %
25.53%
Holding
1,266
New
131
Increased
416
Reduced
568
Closed
116
Top Buys
| 1 |
CRH
CRH
|
$456M |
| 2 |
Boston Scientific
BSX
|
$397M |
| 3 |
Humana
HUM
|
$339M |
| 4 |
T-Mobile US
TMUS
|
$270M |
| 5 |
Thermo Fisher Scientific
TMO
|
$203M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
$479M |
| 2 |
Abbott
ABT
|
$409M |
| 3 |
Elevance Health
ELV
|
$395M |
| 4 |
Danaher
DHR
|
$385M |
| 5 |
Intuit
INTU
|
$256M |
Sector Composition
| 1 | Technology | 24.54% |
| 2 | Healthcare | 14.61% |
| 3 | Financials | 12.81% |
| 4 | Consumer Discretionary | 10.55% |
| 5 | Industrials | 8.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Raymond James Financial
RJF
$34.1B
| $46.3M | 0.06% |
415,333
+33,828
| +9% | +$3.77M |
|
152
ICICI Bank
IBN
$114B
| $43.7M | 0.06% |
1,832,422
-224,055
| -11% | -$5.34M |
|
153
Vertex Pharmaceuticals
VRTX
$102B
| $43.2M | 0.06% |
106,049
-3,079
| -3% | -$1.25M |
|
154
Verra Mobility
VRRM
$3.99B
| $42.6M | 0.06% |
1,849,597
+72,606
| +4% | +$1.67M |
|
155
Cintas
CTAS
$83.4B
| $42.2M | 0.06% |
279,952
-10,820
| -4% | -$1.63M |
|
156
Veralto
VLTO
$26.5B
| $41.3M | 0.05% |
+502,115
| New | +$41.3M |
|
157
S&P Global
SPGI
$165B
| $41.2M | 0.05% |
93,469
-250
| -0.3% | -$110K |
|
158
Federal Signal
FSS
$7.6B
| $40.3M | 0.05% |
524,962
+16,049
| +3% | +$1.23M |
|
|
159
Elevance Health
ELV
$69.4B
| $39.1M | 0.05% |
82,984
-837,076
| -91% | -$395M |
|
160
PayPal
PYPL
$65.4B
| $38.7M | 0.05% |
630,289
+104,328
| +20% | +$6.41M |
|
161
Liberty Global Class A
LBTYA
$4.06B
| $38.1M | 0.05% |
2,142,154
-1,492,855
| -41% | -$26.5M |
|
162
Amgen
AMGN
$151B
| $36.3M | 0.05% |
126,091
-20,165
| -14% | -$5.81M |
|
163
ServiceNow
NOW
$186B
| $36.2M | 0.05% |
51,200
+22
| +0% | +$15.5K |
|
164
Medpace
MEDP
$13.6B
| $35.9M | 0.05% |
117,061
+7,246
| +7% | +$2.22M |
|
165
Nucor
NUE
$33.3B
| $34.1M | 0.05% |
195,781
-515
| -0.3% | -$89.6K |
|
166
Comfort Systems
FIX
$25.5B
| $33.9M | 0.04% |
164,737
+16,179
| +11% | +$3.33M |
|
167
AT&T
T
$212B
| $33.4M | 0.04% |
1,991,231
+531,379
| +36% | +$8.92M |
|
168
iShares Core MSCI Emerging Markets ETF
IEMG
$102B
| $32.1M | 0.04% |
634,506
+355,687
| +128% | +$18M |
|
169
Rocket Pharmaceuticals
RCKT
$349M
| $32.1M | 0.04% |
1,069,715
+70,466
| +7% | +$2.11M |
|
170
Simpson Manufacturing
SSD
$8.03B
| $31.9M | 0.04% |
161,050
+17,501
| +12% | +$3.46M |
|
171
McDonald's
MCD
$226B
| $31.7M | 0.04% |
107,040
+19,941
| +23% | +$5.91M |
|
172
PepsiCo
PEP
$201B
| $31.4M | 0.04% |
184,770
-2,202
| -1% | -$374K |
|
173
Royalty Pharma
RPRX
$16B
| $31.1M | 0.04% |
+1,105,967
| New | +$31.1M |
|
|
DFS
174
DELISTED
Discover Financial Services
DFS
| $30.7M | 0.04% |
273,172
-51,493
| -16% | -$5.79M |
|
175
Cytokinetics
CYTK
$5.95B
| $30.5M | 0.04% |
365,335
+147,486
| +68% | +$12.3M |
|